Skip to main content
Log in

Sequential transarterial chemoembolization for unresectable advanced hepatocellular carcinoma

  • Clinical Investigations
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

Abstract

Purpose

The aim of this prospective study was to evaluate the feasibility, safety, and efficacy of sequential transarterial chemoembolization (TACE) for patients with unresectable advanced hepatocellular carcinoma (HCC).

Methods

Twenty-one consecutive patients with unresectable T3 and T4 HCC were treated by sequential TACE (median time interval between treatments 7 weeks) up to six times with an emulsion of lipiodol, epirubicin, and cisplatin. All TACE procedures were performed as unilobar or whole-liver chemoembolization.

Results

An average of 3.9 TACE procedures were performed per patient. One primary and two secondary technical failures occurred. No procedural death was observed. After exclusion of the patient with the primary technical failure and 3 patients with extrahepatic disease, the survival rates for the remaining 17 patients at 6, 12, 18, and 24 months were 70.6%, 52.9%, 44.1%, and 33.1%, respectively.

Conclusion

Sequential TACE is a safe procedure in patients with unresectable advanced HCC and feasible in most cases. It seems to prolong the survival time compared with historical series of untreated patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Simonetti RG, Camma C, Fiorello F, Politi F, D'Amico G, Pagliaro L (1991) Hepatocellular carcinoma: A worldwide problem and the major risk factors. Dig Dis Sci 36:962–972

    Article  PubMed  CAS  Google Scholar 

  2. Peters RL (1976) Pathology of hepatocellular carcinoma. In: Okuda K, Peters RL (eds) Hepatocellular carcinoma. Wiley, New York, pp 107–169

    Google Scholar 

  3. Okuda K, Obata H, Nakajima Y, Ohtsuki T, Okazaki N, Ohnishi K (1984) Prognosis of primary hepatocellular carcinoma. Hepatology 4:3S-6S

    PubMed  CAS  Google Scholar 

  4. Ringe B, Pichlmayr R, Wittekind C, Tusch G (1991) Surgical treatment of hepatocellular carcinoma: Experience with liver resection and transplantation in 198 patients. World J Surg 15: 270–285

    Article  PubMed  CAS  Google Scholar 

  5. Pichlmayr R, Weimann A, Steinhoff G, Ringe B (1992) Liver transplantation for hepatocellular carcinoma: Clinical results and future aspects. Cancer Chemother Pharmacol 31 [Suppl 1]: S157-S161

    Article  PubMed  Google Scholar 

  6. Falkson G, Moertel CG, Lavin P, Pretorius FJ, Carbone PP (1978) Chemotherapy studies in primary liver cancer. Cancer 42:2149–2156

    Article  PubMed  CAS  Google Scholar 

  7. Charnsangavej C, Chuang VP, Wallace S, Soo CS, Bowers T (1983) Work in progress: Transcatheter management of primary carcinoma of the liver. Radiology 147:51–55

    PubMed  CAS  Google Scholar 

  8. Livraghi T, Bolondi L, Lazzaroni S, Marin G, Morabito A, Rapaccini GL, Salmi A, Torzilli G (1992) Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis: A study of 207 patients. Cancer 69:925–929

    Article  PubMed  CAS  Google Scholar 

  9. Goldstein HM, Wallace S, Anderson JH, Bree RL, Gianturco C (1976) Transcatheter occlusion of abdominal tumors. Radiology 120:539–545

    PubMed  CAS  Google Scholar 

  10. Novell JR, Markham NI, Hobbs KEF (1989) New hope in irresectable hepatoma? Hepatogastroenterology 36:258–261

    PubMed  CAS  Google Scholar 

  11. Shibata J, Fujiyama S, Sato T, Kishimoto S, Fukushima S, Nakano M (1989) Hepatic arterial injection chemotherapy with cisplatin suspended in an oily lymphographic agent for hepatocellular carcinoma. Cancer 64:1586–1594

    Article  PubMed  CAS  Google Scholar 

  12. Monden M, Okamura J, Sakon M, Gotoh M, Kobayashi K, Umeshita K, Yamada T, Kuroda C, Sakurai M, Mori T (1989) Significance of transcatheter chemoembolization combined with surgical resection for hepatocellular carcinoma. Cancer Chemother Pharmacol 23 [Suppl]: S90-S95

    Article  PubMed  Google Scholar 

  13. Hashimoto T, Nakamura H, Hori S, Tomoda K, Nakanishi K, Murakami T, Kozuka T, Monden M, Gotoh M, Kuroda C, Wakasa K, Sakurai M (1995) Hepatocellular carcinoma: Efficacy of transcatheter oily chemoembolization in relation to macroscopic and microscopic patterns of tumor growth among 100 patients with partial hepatectomy. Cardiovasc Intervent Radiol 18:82–86

    PubMed  CAS  Google Scholar 

  14. Monna T, Kanno T, Marumo T, Harihara S, Kuroki T, Yamamoto S, Kobayashi N, Sato M, Nakamura K, Nakatsuka H, Onoyama Y, Yamada R (1982) A comparison of transcatheter arterial embolization with one shot therapy for the patients with hepatic cell carcinoma. Gastroenterol Jpn 17:542–548

    PubMed  CAS  Google Scholar 

  15. Lin D, Liaw Y, Lee T, Lai C (1988) Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma: A randomized controlled trial. Gastroenterology 94:453–456

    PubMed  CAS  Google Scholar 

  16. Ikeda K, Kumada H, Saitoh S, Arase Y, Chayama K (1991) Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma: An analysis by the Cox proportional hazard model. Cancer 68:2150–2154

    Article  PubMed  CAS  Google Scholar 

  17. Pirschel J, Lanchart W (1991) Chemoembolization primärer Leberkarzinome mit Epirubicin-Lipiodol. Fortschr Geb Rontgenstr Nuklearmed 155:409–415

    CAS  Google Scholar 

  18. Vetter D, Wenger J, Bergier J, Doffoel M, Bockel R (1991) Transcatheter oily chemoembolization in the management of advanced hepatocellular carcinoma in cirrhosis: Results of aWestern comparative study in 60 patients. Hepatology 13:427–433

    PubMed  CAS  Google Scholar 

  19. Bismuth H, Morino M, Sherlock D, Castaing D, Miglietta C, Cauquil P, Roche A (1992) Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am J Surg 163:387–394

    Article  PubMed  CAS  Google Scholar 

  20. Hsieh M, Chang W, Wang L, Chen S, Chuang W, Lu S, Wu D (1992) Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization and analysis of prognostic factors. Cancer Chemother Pharmacol 31 [Suppl I]: S82-S85

    Article  PubMed  Google Scholar 

  21. Monden M, Sakon M, Gotoh M, Kanai T, Umeshita K, Wang K, Sakurai M, Kuroda C, Okamura J, Mori T (1992) Selection of therapeutic modalities for hepatocellular carcinoma in patients with multiple hepatic lesions. Cancer Chemother Pharmacol 31 [Suppl I]:S38-S44

    Article  PubMed  Google Scholar 

  22. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire (1995) A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 332:1256–1261

    Article  Google Scholar 

  23. International Union Against Cancer (1993). TNM-Atlas Illustrierter Leitfaden zur TNM/pTNM-Klassifikation maligner Tumoren, 3rd edn. Springer, Berlin Heidelberg New York, pp 104–111

    Google Scholar 

  24. Maki S, Komo T, Maeda H (1985) Image enhancement in computed tomography for sensitive diagnosis of liver cancer and semiquantitation of tumour selective drug targeting with oily contrast. Cancer 56:751–757

    Article  PubMed  CAS  Google Scholar 

  25. Häussler MD, Pfeifer T, Safi F, Friedrich JM, Bargon G (1993) CT-Monitoring bei regionaler Chemotherapie von Lebermetastasen. In: Reiser M, Steudel A, Hirner A, Kania U (eds) Lebertumoren und portale Hypertension: Radiologische und chirurgische Aspekte. Springer, Berlin Heidelberg New York, pp 241–247

    Google Scholar 

  26. Lautt WW, Greenway CV (1987) Conceptual review of the hepatic vascular bed. Hepatology 7:952–963

    Article  PubMed  CAS  Google Scholar 

  27. Kan Z, Wallace S (1994) Sinusoidal embolization: Impact of iodized oil on hepatic microcirculation. J Vasc Intervent Radiol 5:881–886

    CAS  Google Scholar 

  28. Yumoto Y, Jinno K, Tokuyama K, Araki Y, Ishimitsu T, Maeda H, Konno T, Iwamoto S, Ohnishi K, Okuda K (1985) Hepatocellular carcinoma detected by iodized oil. Radiology 154:19–24

    PubMed  CAS  Google Scholar 

  29. Sato M, Yamada R, Uchida B, Hedgepeth P, Rosch J (1993) Effects of hepatic artery embolization with Lipiodol and Gelatin sponge particles on normal swine liver. Cardiovasc Intervent Radiol 16:348–354

    PubMed  CAS  Google Scholar 

  30. Pentecost MJ, Daniels JR, Teitelbaum GP, Stanley P (1993) Hepatic chemoembolization safety with portal vein thrombosis. J Vasc Intervent Radiol 4:347–351

    Article  CAS  Google Scholar 

  31. Toia D, Becker C, Baer HU (1995) Patterns of recurrence of hepatocellular carcinoma after surgery: A radiologic follow-up study. Eur Radiol 5 [Suppl]:S54

    Google Scholar 

  32. Masutani S, Sasaki Y, Imaoka S, Iwamoto S, Ohashi I, Kameyama M, Kabuto T, Ishikawa O, Furukawa H, Koyama H, Iwanaga T (1994) The prognostic significance of surgical margin in liver resection of patients with hepatocellular carcinoma. Arch Surg 129:1025–1030

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jaeger, H.J., Mehring, UM., Castañeda, F. et al. Sequential transarterial chemoembolization for unresectable advanced hepatocellular carcinoma. Cardiovasc Intervent Radiol 19, 388–396 (1996). https://doi.org/10.1007/BF02577625

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02577625

Key words

Navigation